Purple Biotech ADR (PPBT) stock is lower by -55.00% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives PPBT stock a score of 2 out of a possible 100.
That rank is mainly influenced by a short-term technical score of 2. PPBT's rank also includes a long-term technical score of 6.
PPBT has an Overall Score of 2. Find out what this means to you and get the rest of the rankings on PPBT!
Purple Biotech ADR (PPBT) stock is trading at $2.25 as of 12:54 PM on Tuesday, Sep 13, a decline of -$0.03, or -1.32% from the previous closing price of $2.28. The stock has traded between $2.18 and $2.30 so far today. Volume today is less active than usual. So far 24,584 shares have traded compared to average volume of 132,668 shares.
Click Here to get the full Stock Report for Purple Biotech ADR stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
